Explore Our Network

AdhexPharma is an independent contract development and manufacturing organization (CDMO) specializing in oral films and transdermal or topical patches for drug delivery. The company provides comprehensive end-to-end services from feasibility studies and formulation to analytical development, clinical batch production, and commercial manufacturing under cGMP. With expertise in complex dosage forms, handling potent APIs, and meeting global regulatory requirements, AdhexPharma integrates sustainable practices and operates advanced facilities in France and Germany, supporting both large pharmaceutical firms and biotech innovators worldwide.

Advanced BioScience Laboratories, Inc. (ABL) is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics, and other biologic products. ABL leverages its expertise in product development, GMP manufacturing, and immunological testing to support the development of candidate vaccines and therapeutics through preclinical and clinical stages. The company is involved in producing and testing oncolytic viruses, gene therapies, immunotherapies, viral vaccines, and recombinant protein vaccines.

The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization dedicated to advancing the bioeconomy of the United States. Its mission encompasses enhancing manufacturing, healthcare, and education and workforce development, aiming to create a scalable and effective manufacturing ecosystem for engineered cells, tissues, and organs.

Alcamena is dedicated to advancing protein optimization and development through its proprietary directed evolution platform. By leveraging the principles of Darwinian evolution, Alcamena compresses millions of years of evolution into weeks, creating proteins with superior binding affinity and enzymatic activity. The company excels in directed evolution, construct design, library construction, and custom screening techniques, offering solutions that exceed traditional antibody binding affinities and approach the tissue permeability of small molecules. Alcamena's innovations have been validated through collaborations with academic institutions and NIH-funded projects.

Alithia Life Sciences is an Australian-owned, boutique, full-service Contract Research Organization (CRO) dedicated to supporting pharmaceutical, biotechnology, device companies, and institutional research groups with their projects in Australia and beyond. With over 25 years of operational expertise across a wide range of therapeutic areas, Alithia offers personalized project management from Phase I to Phase III, aiming to deliver efficient project outcomes, add value to client programs, and ultimately improve human health and wellbeing.

Ambient Biosciences is a global leader in biostabilization, dedicated to eliminating cold chain reliance and improving global health equity through innovative biomolecule stabilization technology. Their patented Capillary-Assisted Vitrification (CAV) process enables room-temperature storage and shipping of sensitive reagents and biomolecules, offering a superior alternative to traditional lyophilization and cryopreservation. With a values-driven, diverse team of scientific experts and visionary leaders, Ambient Biosciences is committed to transforming laboratory operations, reducing costs and waste, and making life sciences more accessible and sustainable worldwide.

ARIScience is at the forefront of drug discovery, leveraging a unique combination of AI, quantum chemistry, computer vision, and biochemistry to develop novel small molecule drugs. Their mission is to reduce the burden of human disease by discovering therapeutics that interrupt disease pathways. With a focus on neurodegenerative, inflammatory, and infectious diseases, ARIScience employs cutting-edge in silico methods to efficiently identify and optimize drug candidates. Their commitment to innovation and collaboration with leading institutions positions them to make a significant impact on human health. ARIScience is creating value in two ways: Value 1: ARIScience is developing small molecule assets targeting respiratory depression, cutaneous burn and radiation injuries, antivirals for EBOV and DENV, bacteriostatic antibiotic targeting Staph aureus. Value 2: It's novel AI driven quasi quantum chemistry (AI+QQ) small molecule discovery platform for precision protein inhibition and potentiation.

Arizona State University (ASU) is a comprehensive public research university known for its commitment to inclusivity, excellence, and societal impact. ASU is dedicated to advancing research-based solutions for global challenges, fostering strong leadership, and providing quality education accessible to all learners. The university is recognized for its innovative approach to education and its efforts in sustainability, research, and community service. ASU exemplifies a new prototype for the American public research university, focusing on excellence, broad access to quality education, and meaningful societal impact.

The Armed Forces Institute of Regenerative Medicine (AFIRM) , led by the Wake Forest Institute for Regenerative Medicine, is a collaborative effort involving over 30 academic institutions and industry partners. The consortium focuses on advancing regenerative medicine solutions for battlefield injuries, aiming to improve the lives of wounded service members, veterans, and the general public. With a $40 million, five-year award from the Defense Health Agency, AFIRM is dedicated to developing clinical therapies in areas such as craniofacial regeneration, extremity regeneration, genitourinary/lower abdomen, skin and wound healing, on-demand blood, and cellular therapies for trauma.

Arsenal Medical is dedicated to transforming medical devices with innovative biomaterials. Founded by Carmichael Roberts, Robert Langer, and George Whitesides, the company aims to address unmet medical needs through thoughtfully designed products. Their vision is to provide local therapy for important medical conditions across various therapeutic areas, leveraging expertise in materials science and chemistry.

ATCC is a nonprofit biological resource center, with a nearly century-long legacy supporting public health, biodefense, and global health security. ATCC provides critical infrastructure for infectious disease research and CBR threat response. Our biorepository operations support federal agencies, academia, and industry through secure specimen handling, reagent authentication, and global distribution. ATCC manages over 22 million vials under federal contracts, including repositories for NIAID, CDC, BARDA, NCI, FDA, and USDA. These programs enable rapid deployment of validated biological materials for vaccine development, diagnostic assay verification, and therapeutic screening against high-consequence pathogens such as SARS-CoV-2. Certified under ISO 9001, 13485, 17025, and 17034, ATCC ensures quality, traceability, and regulatory compliance across its operations. Our high-containment laboratories (BSL-2 and BSL-3, with access to BSL-4 through partners) and Select Agent license position us to support MTEC-aligned efforts in emerging infectious diseases and medical countermeasure development for CBRN threats.

Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.

Battelle is an independent nonprofit organization dedicated to advancing science and technology to address the world's most pressing challenges. With over 90 years of experience, Battelle transforms knowledge into profound innovation, reinvesting its proceeds into scientific advancement and STEM education. The organization operates across various markets, including health, national security, environment, infrastructure, and industry, providing solutions through limitless innovation and expertise in scientific and engineering disciplines.

Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.

Berry Consultants is a statistical consulting company specializing in innovative clinical trial design, analysis, implementation, and software solutions for the pharmaceutical and medical device industry. They focus on adaptive clinical trials and Bayesian analysis, aiming to improve the efficiency and effectiveness of clinical research.

BioBridge Global is a nonprofit organization dedicated to saving and enhancing lives through the healing power of human cells and tissue. It operates a family of nonprofits including South Texas Blood & Tissue, QualTex Laboratories, GenCure, and The Blood & Tissue Center Foundation. The organization provides lifesaving therapies to patients and supports advances in advanced therapies, focusing on blood, cell, and tissue products, testing services, and the development of new therapies.

BioFactura, Inc., based in Frederick, Maryland, is a biopharmaceutical company specializing in the development and commercialization of high-value biosimilars, biodefense medical countermeasures, and novel drugs. Leveraging its proprietary StableFast™ Biomanufacturing Platform, BioFactura delivers faster, lower-cost, and superior-quality biologics. With over a decade of experience, the company has advanced life-saving medicines from research to patient care, focusing on unmet global biomedical and national biodefense needs. Its portfolio includes drugs for smallpox, Ebola, cancer, autoimmune, and infectious diseases.

BioTechnique® is a full-service Contract Research Development and Manufacturing Organization (CRDMO) specializing in sterile injectable fill-finish services. With a commitment to quality and innovation, BioTechnique® aims to enhance healthcare outcomes worldwide by providing high-quality life-saving products and maintaining the highest standards in pharmaceutical manufacturing.

Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.

BrightFocus Foundation is a leading nonprofit organization dedicated to funding innovative scientific research and providing expert information to defeat Alzheimer’s disease, macular degeneration, and glaucoma. With a mission to envision a world where everyone can age free from diseases of mind and sight, BrightFocus invests in groundbreaking research, supports the next generation of scientists, and empowers individuals and families with trusted resources. Over its 50-year history, the foundation has awarded nearly $300 million in research grants to more than 6,000 scientists worldwide, catalyzing life-changing breakthroughs and advancing public education on brain and vision health. The foundation's impact is evident in major scientific milestones, such as the first successful cell transplantation for glaucoma, FDA "Breakthrough Therapy" designations, and the development of new diagnostic and therapeutic approaches for neurodegenerative and vision diseases.